PER1 suppresses glycolysis and cell proliferation in oral squamous cell carcinoma via the PER1/RACK1/PI3K signaling complex
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PER1 suppresses glycolysis and cell proliferation in oral squamous cell carcinoma via the PER1/RACK1/PI3K signaling complex
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 12, Issue 3, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-15
DOI
10.1038/s41419-021-03563-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway
- (2020) Guojun Yang et al. CANCER SCIENCE
- B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2
- (2019) Tongguo Shi et al. Cell Death & Disease
- The changing therapeutic landscape of head and neck cancer
- (2019) John D. Cramer et al. Nature Reviews Clinical Oncology
- Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer
- (2019) Goran Hamid Mohammad et al. Cancers
- SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer
- (2019) Tian Gao et al. CANCER LETTERS
- Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway
- (2018) Jing Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway
- (2018) Teng Hou et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- BMAL1 and CLOCK proteins in regulating UVB-induced apoptosis and DNA damage responses in human keratinocytes
- (2018) Yang Sun et al. JOURNAL OF CELLULAR PHYSIOLOGY
- RACK1 is an organ-specific prognostic predictor in OSCC
- (2018) Sai Liu et al. ORAL ONCOLOGY
- Altered circadian genes expression in breast cancer tissue according to the clinical characteristics
- (2018) Monika Lesicka et al. PLoS One
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer
- (2018) Josephraj Sophia et al. Cell Death & Disease
- RACK1 promotes tumorigenicity of colon cancer by inducing cell autophagy
- (2018) Ta Xiao et al. Cell Death & Disease
- Maximising the potential of AKT inhibitors as anti-cancer treatments
- (2017) Jessica S. Brown et al. PHARMACOLOGY & THERAPEUTICS
- The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012
- (2016) Kevin D. Shield et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway
- (2016) Xuefeng Zhang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- A new mechanism of trastuzumab resistance in gastric cancer: MACC1 promotes the Warburg effect via activation of the PI3K/AKT signaling pathway
- (2016) Jing Liu et al. Journal of Hematology & Oncology
- miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth
- (2016) Yuyan Han et al. JOURNAL OF HEPATOLOGY
- Transcriptional architecture of the mammalian circadian clock
- (2016) Joseph S. Takahashi NATURE REVIEWS GENETICS
- Circadian clock gene Per2 plays an important role in cell proliferation, apoptosis and cell cycle progression in human oral squamous cell carcinoma
- (2016) QINGQING WANG et al. ONCOLOGY REPORTS
- Long noncoding RNA AK126698 inhibits proliferation and migration of non-small cell lung cancer cells by targeting Frizzled-8 and suppressing Wnt/β-catenin signaling pathway
- (2016) Xiao Fu et al. OncoTargets and Therapy
- PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis
- (2016) Ji Liang et al. Nature Communications
- The core clock genePer1phases molecular and electrical circadian rhythms in SCN neurons
- (2016) Jeff R. Jones et al. PeerJ
- Oral cavity and oropharyngeal squamous cell carcinoma-an update
- (2015) Angela C. Chi et al. CA-A CANCER JOURNAL FOR CLINICIANS
- 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy
- (2014) Dongsheng Zhang et al. CANCER LETTERS
- RACK1 promotes the proliferation, migration and invasion capacity of mouse hepatocellular carcinoma cell line in vitro probably by PI3K/Rac1 signaling pathway
- (2013) Jun Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- Nuclear PKM2 regulates the Warburg effect
- (2013) Weiwei Yang et al. CELL CYCLE
- Lactate dehydrogenase a in cancer: A promising target for diagnosis and therapy
- (2013) Ping Miao et al. IUBMB LIFE
- Tumor glycolysis as a target for cancer therapy: progress and prospects
- (2013) Shanmugasundaram Ganapathy-Kanniappan et al. Molecular Cancer
- Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells
- (2013) Yefei Rong et al. TUMOR BIOLOGY
- Unwinding the differences of the mammalian PERIOD clock proteins from crystal structure to cellular function
- (2012) N. Kucera et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex
- (2012) Guo Li et al. Nature Communications
- The Mammalian Circadian Timing System: Organization and Coordination of Central and Peripheral Clocks
- (2010) Charna Dibner et al. Annual Review of Physiology
- RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo
- (2009) Xi-Xi Cao et al. BREAST CANCER RESEARCH AND TREATMENT
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now